INDIANAPOLIS, Nov. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine ...

Eli Lilly & Co. lowered guidance on lackluster sales of its blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro.

INDIANAPOLIS, Oct. 30, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third quarter of 2024. "Lilly had another strong growth quarter in Q3, with ...

Eli Lilly, one of our best picks for the Charitable Trust… And that’s had quite a run thanks to the GLP-1 weight loss drugs. This morning, Stifel brokerage house put out a note that talks ...

Post-approval safety issues arose for a third of novel drugs approved from 2001 through 2010, leading a small number to be ...

Italy's Prysmian and Britain's TechnipFMC signed an agreement to strengthen the development of floating offshore wind ...

Lots of money is pouring into two critical races for Washington's legislature this year — and some big name companies are ...

Eli Lilly has thrown its weight behind a cause beyond ... need to use the restroom frequently when they leave the house. And people with ulcerative colitis are almost three times as likely to ...

The drugs whose labels were updated include Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro ... Compounding group ...

The newest addition to Eli Lilly and Co.’s manufacturing ... Bringing them back in-house can speed up production, Lilly said. Technologies developed at the foundry will be transferred to Lilly ...

This remarkable estate at The Landing on Lake Grapevine is secluded, private and super dog-friendly, just ask Loretta Lynn's ...